Select Page

LC-MS/MS Method of Fingolimod in Human Whole Blood: Is Sensitivity and Required Blood Volume an Issue?

PRESENTED TO: BioPharma Services Inc.
PRESENTED BY: J. PATEL

PURPOSE

LC-MS/MS Method of Fingolimod in Human Whole Blood: Is Sensitivity and Required Blood Volume an Issue? – The current LC-MS/MS method outline the process for highly sensitive assay of fingolimod from human whole blood in K2-EDTA.

Currently available methods within the industry are sensitive enough to achieve the LLOQ of 50 pg/mL only, using high sample
volume ranges between 0.7mL to 1mL, which leads to high volume of blood drawn from the volunteers during clinical trials. Our method has been successfully developed to achieve a high sensitivity at 5pg/mL and using 0.35mL sample volume only. Selectivity, matrix factor, matrix effect, recovery, robustness and stabilities were evaluated during vigorous approach of validation.

To access the entire publication and view the full resolution PDF, please complete the form.

LC-MS/MS Method of Fingolimod in Human Whole Blood: Is Sensitivity and Required Blood Volume an Issue?

Download Publication

BioPharma Services Inc. is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below to say how you would like us to contact you:
In order to provide you the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please tick the checkbox below.
You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

Popular Posts